ArticleScientific reports2025
SOuLMuSiC, a novel tool for predicting the impact of mutations on protein solubility.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Engineering of a Carbonic Anhydrase fromInternational journal of molecular sciences · 2026Article
- Global Analysis of Aggregation Determinants in Small Protein Domains.bioRxiv : the preprint server for biology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Protein solubility problems arise in a wide range of applications, from antibody development to enzyme production, and are linked to several major disorders, including cataracts and Alzheimer's diseases. To assist scientists in designing proteins with improved solubility and better understand solubility-related diseases, we introduce SOuLMuSiC, a computational tool for the fast and accurate prediction of the impact of single-site mutations on protein solubility. Our model is based on a simple artificial neural network that takes as input a series of features, including biophysical properties of wild-type and mutated residues, energetic values computed using various statistical potentials, and mutational scores derived from protein language models. SOuLMuSiC has been trained on a curated dataset of about 700 single-site mutations with known solubility values, collected and manually verified from original literature. It significantly outperforms current state-of-the-art predictors in strict cross validation: the Spearman correlation reaches 0.5 when solubility changes are represented categorically; for the subset with quantitative values, it increases to 0.7. SOuLMuSiC also shows good performance on external datasets containing high-throughput enzyme solubility-related data as well as protein aggregation propensities. In summary, SOuLMuSiC is a valuable tool for identifying mutations that impact protein solubility, and can play a major role in the rational design of proteins with improved solubility and in understanding genetic variants' effect. It is freely available for academic use at http://babylone.ulb.ac.be/SoulMuSiC/.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.